Document 65 - Assort Design

Document #65 R&D

Source: url • Audience: r_and_d • Status: completed

Routing confidence: 95% • Candidates: R&D, Medical Affairs

Routing reasons: ML fallback: low confidence (41% < 57%); The document discusses genetic research on non-alcoholic steatohepatitis (NASH) involving gene mutation studies in mice, which is typical of research and development content.; The content includes detailed experimental methods such as use of albino and black B6 mice, gene mutation analysis, and dietary impact on disease progression, indicating a focus on scientific investigation.; The document cites a scientific journal reference and explains molecular and genetic mechanisms, which are of primary interest to researchers and scientists in the biomedical field.

Back to Request Back Home

Researchers uncover new genetic link to non-alcoholic steatohepatitis Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge eBooks Posters Podcasts Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Breastfeeding Cold, Flu & Cough Dermat...

Show full document

Researchers uncover new genetic link to non-alcoholic steatohepatitis Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge eBooks Posters Podcasts Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Breastfeeding Cold, Flu & Cough Dermatology Diabetes Eating Disorders Eye Health Gastrointestinal Health Heart Disease Lung Cancer Mental Health Parkinson's Disease Pregnancy Sleep Urology View Health A-Z × Top Health Categories Coronavirus Disease COVID-19 Eating Disorders Diet & Nutrition Eye Health Artificial Intelligence Gastrointestinal Health Allergies Heart Disease Alzheimer's & Dementia Lung Cancer Arthritis & Rheumatology Mental Health Breast Cancer Parkinson's Disease Breastfeeding Pregnancy Cold, Flu & Cough Sleep Dermatology Urology Diabetes View Health A-Z Medical Home Life Sciences Home About News Life Sciences A-Z White Papers Lab Equipment Interviews Newsletters Webinars More... eBooks Posters Podcasts Contact Meet the Team Advertise Search Become a Member White Papers MediKnowledge eBooks Posters Podcasts Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Webinars eBooks Posters Podcasts Contact Meet the Team Advertise Search Become a Member Researchers uncover new genetic link to non-alcoholic steatohepatitis Download PDF Copy Reviewed Reviewed by Emily Henderson, B.Sc. Nov 10 2021 Non-alcoholic fatty liver disease (NAFLD) is the accumulation of fat in the liver unrelated to alcohol abuse or other liver diseases. It is often associated with obesity and diabetes and is considered a manifestation of metabolic syndrome. It progresses into non-alcoholic steatohepatitis (NASH) with the onset of inflammation , although it is currently unclear how this occurs. NASH can lead to severe complications such as liver failure, cirrhosis, and liver cancer. Now, a team led by the University of Tsukuba has found that albino mice with a point mutation in the tyrosinase gene are more susceptible to NASH than mice carrying the non-mutated gene. The prevalence and severity of NAFLD are known to vary between different human ethnicities, with the highest prevalence in Hispanic populations. The tyrosinase gene encodes an enzyme that is involved in melanin production , affecting skin tone. The team observed in preliminary computational analyses that different point mutations in the tyrosinase gene also vary in frequency between different ethnic groups, with the two main variants observed at high frequencies in Hispanic populations. The researchers therefore hypothesized that tyrosinase gene variants could possibly affect the susceptibility and severity of NAFLD and NASH. The team studied a particular mouse line known as "C57BL/6", or B6, to test this hypothesis. Albino B6 mice have a single change, known as a point mutation, in the gene tyrosinase. This affects the function of the tyrosinase enzyme so that the albino mice cannot produce melanin properly, losing pigmentation and becoming white instead of black. Dietary cholesterol contributes to the development of liver inflammation, and so the team fed both albino and black B6 mice a high cholesterol diet for 10 weeks. They found that black B6 mice exhibited no symptoms over the entire course of the diet, while approximately 50% of the albino B6 mice showed a severe phenotype, developing liver injury after a single day that progressed to NASH after 2 weeks. The team further showed that the albino B6 mice showed high expression of tyrosinase in the small intestine. "This could affect the susceptibility of the mice to NASH by affecting the uptake of cholesterol in the small intestine," says senior author Assistant Professor Michito Hamada, "pointing to a potential mechanism for this increased susceptibility." As the point mutation in the tyrosinase gene is the only genetic difference between B6 albino and B6 black mice. Our work will facilitate the identification of genetic susceptibility factors for the development of NASH and expand the understanding of the pathophysiology of NASH." Michito Hamada, Assistant Professor, University of Tsukuba Source: University of Tsukuba Journal reference: Kulathunga, K., et al. (2021) Albino mice with the point mutation at the tyrosinase locus show high cholesterol diet-induced NASH susceptibility. Scientific Reports . doi.org/10.1038/s41598-021-00501-5 . Posted in: Medical Science News | Medical Research News | Medical Condition News Comments (0) Download PDF Copy Suggested Reading Study reveals how inherited genetic abnormalities raise Barrett’s esophagus risk Type 2 diabetes and hypertension share a genetic link, study shows Obesity drives shared genetic risk behind many chronic disease combinations Genetic variants in 11 regions of human genome influence the gut microbiome Study explores whether a bidirectional causal link exists between MASLD and sarcopenia Researchers develop new score to predict the risk of liver cancer SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene therapies Cornell study finds existing drug could boost liver cancer immunotherapy Comments The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical. Cancel reply to comment Post a new comment Login (Logout) Quirky Comment Title Post Sign in to keep reading We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free. Sign in with Google Sign in with Apple Sign in with LinkedIn Sign in with Facebook or Sign in with email Trending Stories Latest Interviews Top Health Articles Case report examines potential cancer risks after mRNA vaccination Study uncovers immune trigger behind vaccine-induced immune thrombocytopenia and thrombosis Nasal COVID vaccine boost increases IgA responses linked to variant neutralisation Researchers identify a previously unknown cellular barrier in the brain Ozempic users continue treatment when weight loss works despite side effects Advancing brain microphysiological systems (bMPS) Dr. Lena Smirnova Brain microphysiological systems are reshaping in vitro neurotoxicity testing through functional validation and advanced disease modeling. PhD researcher at LifeArc Natasha Bury Targeted protein degradation presents a promising strategy to address antimicrobial resistance, focusing on innovative approaches for gram-negative bacteria. Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research Rosanna Zhang In our latest interview, News-Medical speaks with Rosanna Zhang from ACROBiosystems about utilizing organoids for disease modeling in the field of neuroscience research. Astaxanthin and Human Health: Evidence on Skin, Vision, Brain, and Aging The Gut–Brain–Skin Axis: How Diet and Gut Health Influence Mood, Skin, and Aging How Morning Routines Influence Cognitive Performance, Mood, and Circadian Rhythm Camel Milk Nutrition Facts and Potential Health Benefits Explained Edible Insects as Food: Nutritional Benefits, Safety, and Environmental Impact Latest News Researchers discover a way to breach cancer’s impenetrable fortress Weekend holiday rehabilitation supports recovery in elderly hip fracture patients Novel implant delivers tiny growth-promoting particles directly to injured nerve cells Changes in lymphatic vessels can help identify aggressive oral cancer at an early stage Axol Bioscience acquires ophthalmology business from Newcells Biotech Newsletters you may be interested in Genetics ( Subscribe or Preview ) Cholesterol ( Subscribe or Preview ) Diabetes ( Subscribe or Preview ) See all Newsletters » High Credibility: This website adheres to all nine standards of credibility and transparency. Medical Links Medical Home Functional Food News Health A-Z White Papers Thought Leaders Insights MediKnowledge Series Health & Personal Care Medical Devices Drugs eBooks Posters Podcasts Life Sciences Links Life Sciences Home News Lab Instruments & Equipment Life Sciences A-Z White Papers Thought Leaders Insights Webinars eBooks Posters Podcasts Other Useful Links About Meet the Team Search Newsletters Sitemap Advertise Contact Terms & Conditions Privacy & Cookie Policy Content Policy Ownership & Funding Information Other AZoNetwork Sites AZoM AZoNano AZoCleantech AZoOptics AZoRobotics AZoSensors AZoMining AZoQuantum AZoBuild AZoLifeSciences AZoAi Facebook Twitter LinkedIn News-Medical.Net provides this medical information service in accordance with these terms and conditions . Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Update Your Privacy Preferences Last Updated: Wednesday 18 Feb 2026 News-Medical.net - An AZoNetwork Site Owned and operated by AZoNetwork, © 2000-2026 Azthena logo with the word Azthena Maximise chat window Hide chat window Your AI Powered Scientific Assistant Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. To start a conversation, please log into your AZoProfile account first, or create a new account. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content . Log in A few things you need to know before we start. Please read and accept to continue. Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI . Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy . Large Language Models can make mistakes. Consider checking important information. I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements. Please check the box above to proceed. Start Chat Great. Ask your question. Clear Chat Clear Chat Brief Moderate Detailed Azthena may occasionally provide inaccurate responses. Read the full terms . Terms While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information. Read the full Terms & Conditions . Provide Feedback Submit Cancel You might also like... × Telehealth boosts uptake of genetic testing among adult survivors of childhood cancers

One-line Summary

A point mutation in the tyrosinase gene increases susceptibility to diet-induced NASH in albino mice via altered cholesterol uptake in the intestine, suggesting genetic influence on NASH pathophysiology.

Decision Bullets

Expected: 3–5 bullets.

Technical Summary: The study used genetically identical B6 mice differing only by a tyrosinase point mutation to demonstrate increased NASH susceptibility driven by cholesterol diet and altered intestinal cholesterol uptake.
Assumptions: The tyrosinase mutation solely accounts for phenotype differences; murine results extrapolate to human ethnic genetic variability in NAFLD susceptibility.
Key Risks: Confounding factors influencing NASH development beyond tyrosinase mutation remain untested; interspecies differences may limit translational validity.
Experimental Plan: Validate cholesterol absorption differences in intestinal tissue; conduct gene expression and functional assays focusing on lipid metabolism pathways; perform epidemiological studies correlating human tyrosinase variants with NAFLD severity.
Next Steps: Develop targeted interventions modulating tyrosinase-related pathways; expand mouse model studies including other tyrosinase variants; initiate clinical genetic association analyses in high-risk populations.

Mind Map

mindmap
  root((Tyrosinase Mutation and NASH))
    Genetic Link
      Tyrosinase Gene
      Point Mutation
      Albino B6 Mouse Model
      Ethnic Variability
    Experimental Setup
      High Cholesterol Diet
      Comparison: Albino vs Black Mice
      Phenotype Assessment
    Mechanisms
      Melanin Production Impairment
      Intestinal Tyrosinase Expression
      Cholesterol Uptake Alteration
    Outcomes
      NASH Development
      Liver Injury
      Metabolic Syndrome Link
    Future Plans
      Cholesterol Absorption Studies
      Gene Expression Profiling
      Human Genetic Association
      Therapeutic Targeting

If needed, use the in-page "View source" button on the job detail page to see the raw mind map.

Key Clues

Albino B6 mice carry a point mutation in tyrosinase gene
High cholesterol diet induces NASH only in albino, not black B6 mice
Tyrosinase expressed highly in albino mice’s small intestine
Mutation alters melanin production and may affect cholesterol uptake
Ethnic variability in tyrosinase variants correlates with NAFLD prevalence

Tag Intelligence

Domain: General / Other

Canonical tags

non-alcoholic steatohepatitis
tyrosinase gene
genetic susceptibility
cholesterol metabolism
mouse model
metabolic syndrome

View Tag Insights

Tool Summary

Low support: fewer than 3 cited claims.

Citations: 2

Technical Summary: The study used genetically identical B6 mice differing only by a tyrosinase point mutation to demonstrate increased NASH susceptibility driven by cholesterol diet and altered intestinal cholesterol uptake.

"This could affect the susceptibility of the mice to NASH by affecting the uptake of cholesterol in the small intestine," says senior author Assistant Professor Michito Hamada, "pointing to a potential mechanism for this increased susceptibility.

…er 2 weeks. The team further showed that the albino B6 mice showed high expression of tyrosinase in the small intestine. "This could affect the susceptibility of the mice to NASH by affecting the uptake of cholesterol in the small intestine," says senior author Assistant Professor Michito Hamada, "pointing to a potential mechanism for this increased susceptibility ." As the point mutation in the tyrosinase gene is the only genetic difference between B6 albino and B6 black mice. Our …

Assumptions: The tyrosinase mutation solely accounts for phenotype differences; murine results extrapolate to human ethnic genetic variability in NAFLD susceptibility.

Now, a team led by the University of Tsukuba has found that albino mice with a point mutation in the tyrosinase gene are more susceptible to NASH than mice carrying the non-mutated gene.

…ently unclear how this occurs. NASH can lead to severe complications such as liver failure, cirrhosis, and liver cancer. Now, a team led by the University of Tsukuba has found that albino mice with a point mutation in the tyrosinase gene are more susceptible to NASH than mice carrying the non-mutated gene . The prevalence and severity of NAFLD are known to vary between different human ethnicities, with the highest prevalenc…

Next Steps: Develop targeted interventions modulating tyrosinase-related pathways; expand mouse model studies including other tyrosinase variants; initiate clinical genetic association analyses in high-risk populations.

No supporting quote found.

Risk flags: 1 High · 0 Medium · 0 Low

High severity risk detected.